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The reprogramming factors that induce pluripotency
have been identified primarily from embryonic stem
cell (ESC)-enriched, pluripotency-associated fac-
tors. Here, we report that, during mouse somatic
cell reprogramming, pluripotency can be induced
with lineage specifiers that are pluripotency rivals
to suppress ESC identity, most of which are not
enriched in ESCs. We found that OCT4 and SOX2,
the core regulators of pluripotency, can be replaced
by lineage specifiers that are involved in mesendo-
dermal (ME) specification and in ectodermal (ECT)
specification, respectively. OCT4 and its substitutes
attenuated the elevated expression of a group of ECT
genes, whereas SOX2 and its substitutes curtailed a
group of ME genes during reprogramming. Surpris-
ingly, the two counteracting lineage specifiers can
synergistically induce pluripotency in the absence
of both OCT4 and SOX2. Our study suggests a
‘‘seesaw model’’ in which a balance that is estab-
lished using pluripotency factors and/or counteract-
ing lineage specifiers can facilitate reprogramming.
INTRODUCTION
Understanding the establishment of cellular identity in program-
ming and reprogramming is a major goal of modern biology. For
years, pluripotency-associated factors and their rivals, lineage
specifiers, have generally been considered to determine the
identities of pluripotent and differentiated cells, respectively
(Jaenisch and Young, 2008; Young, 2011). Accordingly, thereprogramming factors that induce pluripotency have been iden-
tified primarily from embryonic stem cell (ESC)-enriched factors,
pluripotency-associated factors, or maternal factors such as
Oct4, Sox2, Klf4, c-Myc, Nanog, PRDM14, Sall4, Esrrb, Utf1,
Tet2, and Glis1 (Aoi et al., 2008; Buganim et al., 2012; Chia
et al., 2010; Doege et al., 2012; Maekawa et al., 2011; Maherali
et al., 2008; Takahashi and Yamanaka, 2006; Yu et al., 2007).
Likewise, the direct reprogramming of differentiated cells into
other differentiated cell types has been successfully demon-
strated by several lineage specifiers, such as Gata4 and Hnf4a
(Vierbuchen and Wernig, 2011). Thus, the perspective that the
direct conversion of cell state A to cell state B should be realized
by a set of master regulatory factors of cell type B has been a
prevailing strategy (Graf and Enver, 2009; Jopling et al., 2011);
however, whether this is the only strategy for cell fate conversion
is unclear.
Recent data indicate that the most critical reprogramming
factor, Oct4, which inhibits the expression of differentiation-
related genes in ESCs (Kim et al., 2008; Pardo et al., 2010), is suf-
ficient to direct the reprogramming of somatic cells into induced
pluripotent stem cells (iPSCs) (Li et al., 2011; Zhu et al., 2010).
Therefore, it is of great significance to find substitutes for Oct4
to elucidate its physiological role and gain a better understand-
ing of the reprogramming mechanisms, which remain largely
unknown. The ESC-enriched factor Nr5a2 has been identified
as an Oct4 substitute (Heng et al., 2010). However, the physio-
logical role of Oct4 remains unclear because Nr5a2 directly reg-
ulates Oct4 and binds to the upstream promoter region of Oct4
(Gu et al., 2005; Guo and Smith, 2010). Therefore, extensively
screening for novel Oct4 substitutes among factors including
but not limited to ESC-related factors may cast light on
the molecular mechanisms that underlie reprogramming and
pluripotency, thereby facilitating the development of safer and
more efficient reprogramming strategies.Cell 153, 963–975, May 23, 2013 ª2013 Elsevier Inc. 963
Figure 1. GATA3 Can Substitute for OCT4 to Induce Pluripotency in Mouse Somatic Cells
(A) Schematic representation of the gene-screening process. For the screen, a plasmid library of 10,080 human geneswas analyzed. AnOCT4 plasmid and empty
vectors (EV) were used as positive and negative controls in the first and second column, respectively.
(B) Reprogramming assay that determines the ability of the lineage specifierGATA3 to enhance reprogramming in the absence ofOCT4, SOX2, KLF4, or c-MYC.
TheOct4-GFP-positive colonies were counted at 9 days postinfection (dpi). SKM, OKM, OSM, OSK, and SK plus EV were used as negative controls. OSKMwas
used as a positive control. Error bars indicate the SD (n = 3).
(C) The kinetics of reprogramming using different combinations of genes. For the 50,000MEFs seeded per well, the GFP fluorescence wasmonitored every 24 hr.
The orange bars indicate that no Oct4-GFP-positive cells were observed, whereas the green bars indicate the emergence of Oct4-GFP-positive cells. Two
representative independent experimental sets are shown.
(legend continued on next page)
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Here, we identified eight lineage specifiers as OCT4 substi-
tutes, including GATA3, GATA6, and SOX7, which are involved
in mesendodermal (ME) lineage specification. OCT4 and its
substitutes attenuated the elevated expression of a group of
ectodermal (ECT) genes, such as the ECT lineage specifier
Dlx3, that were collectively triggered by SOX2, KLF4, and
c-MYC (SKM). Knockdown of Dlx3 enhanced reprogramming
in the absence of OCT4, rather than in the absence of SOX2. In
addition, SOX2 can be replaced by lineage specifiers involved
in ECT lineage specification, such as GMNN. Surprisingly, the
two counteracting lineage specifiers can synergistically induce
pluripotency in the absence of both OCT4 and SOX2. We
suggest a ‘‘seesaw model’’ in which the balance that is estab-
lished by pluripotency factors and/or lineage specifiers facili-
tates the induction of pluripotency in somatic cells. This model
could shed light on fundamental questions regarding the
establishment of cellular identity during programming and
reprogramming.
RESULTS
Induction of Pluripotency in Mouse Somatic Cells
with GATA3
In our study, we screened an initial plasmid library of 10,080
human genes for their ability to replace OCT4 when introduced
together with virally expressed SKM to direct the reprogramming
of mouse embryonic fibroblasts (MEFs) containing a green fluo-
rescent protein (GFP) reporter driven by an Oct4 promoter and
enhancer. Reprogramming efficiency was evaluated by deter-
mining the number of Oct4-driven GFP-positive colonies. We
found that GATA3 had the most significant effect in the primary
hits (Figure 1A and Table S1 available online). Interestingly,
GATA3 is not enriched in ESCs and is an important regulator of
development and differentiation (Figure S1D and Table S4)
(Ting et al., 1996).
We further validated the ability of GATA3 to replace OCT4
during the reprogramming of MEFs, mouse adult dermal fibro-
blasts (MDFs), mouse gastric epithelial cells (GECs), and mouse
keratinocytes using viral vectors (Figures 1B, S1A, and S1B). The
expression of exogenous genes was verified (Figure S1E). We
found that GATA3 achieved a reprogramming efficiency that
was comparable to or even higher than that of OCT4. We subse-
quently evaluated the ability of GATA3 to enhance reprogram-
ming in the absence of SOX2, KLF4, or c-MYC. We observed
that GATA3 was also able to enhance reprogramming in the
absence of c-MYC, but it was unable to substitute for SOX2 or(D) The Oct4-GFP-positive colonies generated by dox-inducible GATA3 and con
medium for various periods of time to induce the expression of GATA3. SKM plu
(E) The generation of iPS colonies with G3SKM fromOct4-GFPMEFs. Phase andG
the expression of NANOG in iPS colonies are depicted from left to right. Scale b
(F) An adult chimeric mouse (left) generated fromG3SKM-induced iPSCs (#1). Pha
G3SKM-iPS-#1 chimeric embryo.
(G) Germline transmission mice (agouti) from #1 are depicted.
(H) The flow cytometric analysis of GFP in G3SKM-secondary MEFs without
endogenousOct4 in G3SKM-secondaryMEFs in the process of dox induction. Re
indicate the SD (n = 3).
See also Figures S1 and S2 and Tables S1 and S2.KLF4 (Figure 1B). Next, we monitored the kinetics of GATA3-
and OCT4-induced reprogramming. We found that Oct4-GFP-
positive cells emerged at 6–7 days postinfection (dpi) during
both GATA3- and OCT4-induced reprogramming (Figure 1C).
We found thatGATA3maymainly function at 4–7 dpi (Figure 1D),
which corresponds to the period during which the pluripotency
circuitry is reconstructed (Polo et al., 2012).
iPSCs Generated with GATA3 Are Pluripotent
The iPSCs generated using GATA3, SOX2, KLF4, and c-MYC
(G3SKM) had morphology similar to mouse ESCs (Figures 1E
and S2A). The G3SKM-induced iPSCs were stable during
long-term passaging and stained positive for alkaline phospha-
tase (AP), SSEA-1, UTF1, and NANOG (Figures 1E, S2A, and
S2B). The methylation levels of the Nanog and Oct4 promoters
were similar to the methylation levels in mouse ESCs (Fig-
ure S2C). Genomic integrations of the viruses into the genomic
DNA were confirmed in iPSCs, teratomas, and tissues from
chimeric mice, and showed no OCT4 transgene integration
(Figure S2D). The expression of endogenous pluripotency-
associated genes was activated, and the expression of exoge-
nous GATA3, SOX2, KLF4, and c-MYC was silenced in these
cells (Figure S2E), which indicates that they were fully reprog-
rammed. G3SKM-induced iPSCs produced germline-compe-
tent chimeras (Figures 1F and 1G), and these iPSCs were further
validated by the characterization of teratoma formation, gene
expression profiles, and other assays (Figures S2F and S2G
and Tables S2).
GATA3 Has Little Effect on the Events Noted in Previous
Studies
To identify the potential mechanisms by which GATA3 could
replace OCT4, we examined several pathways that have been
reported to facilitate or inhibit reprogramming. To test whether
GATA3 could activate endogenous Oct4 to a high level shortly
after induction so that it was the activated endogenous Oct4
plus SKM that induced pluripotency, we monitored the endoge-
nous Oct4 expression levels using doxycycline (dox)-inducible
G3SKM-secondary MEFs (Wernig et al., 2008), 20%–40% of
which could be reprogrammed. We did not detect significant
Oct4 activation until Oct4-GFP-positive cells had begun to
emerge (Figure 1H). There was also no significant activation
of the pluripotency-associated factor Nanog until Oct4-GFP-
positive cells began to emerge (Figure S1C).
We found that GATA3 had little effect on mesenchymal-
epithelial transition (MET) (Figure 2A) (Li et al., 2010;stantly expressed SKM were counted at 10 dpi. Dox was added to the culture
s EV was used as a negative control. Error bars indicate the SD (n = 3).
FP images of a primary iPS colony, GFP images of passaged iPS colonies, and
ars, 100 mm.
se (middle) and GFP (right) images of the male gonads dissected from an E13.5
(left) and with (middle) dox. RT-qPCR analysis of the relative expression of
presentative results from three independent experiments are shown. Error bars
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Figure 2. OCT4 and GATA3 Can Inhibit a Group of ECT Genes that Are Elevated by SKM during Reprogramming
(A) RT-qPCR analysis of the expression of endogenous Cdh1, Cdh2, Snai1, p53, and p21 relative to their expression in MEFs. The samples were tested at 4 dpi.
Error bars indicate the SD (n = 3).
(B) Cell proliferation curves. SKM was used as a control, and 50,000 MEFs were seeded per well. Three wells were harvested every 24 hr to count the number of
cells. The cell populations were analyzed using a paired two-tailed Student’s t test. No significant difference was observed between G3SKM- and SKM-infected
MEFs (p = 0.7803). Error bars indicate the SD (n = 3).
(C) A Venn diagram illustrating the overlap between the expression changes identified in cells induced with G3SKM and OSKM. The blue circle represents the DE
lists (expression change > 2-fold, p < 0.05, FDR < 0.01) in G3SKM-induced cells compared with SKM-induced cells. The purple circle represents the DE lists of
OSKM-induced cells compared with SKM-induced cells.
(D) Gene ontology (GO) analysis of the overlapping genes in (C). The GO analysis was based on the DE list. The p values represent the Bonferroni-corrected EASE
score.
(E) GO analysis of genes regulated by SKM, G3SKM, and OSKM at 7 dpi. The GO analysis was based on the DE list. The p values represent the Bonferroni-
corrected EASE score.
(F) Heatmaps depicting the relative fold change of gene expression at 7 dpi based on the ECT-related genes by RNA-seq. Red and green indicate increased and
decreased expression, respectively.Samavarchi-Tehrani et al., 2010). In addition, p53 and p21
expression was not affected by GATA3 (Figure 2A) (Zhao et al.,
2008). Moreover, we did not observe any significant changes
in cell proliferation (Figure 2B), which suggests that GATA3966 Cell 153, 963–975, May 23, 2013 ª2013 Elsevier Inc.does not contribute to reprogramming by accelerating cell prolif-
eration. These results suggest thatGATA3 functions in a manner
different from the mechanisms noted in previous studies to pro-
mote reprogramming.
OCT4 and GATA3 Inhibit the ECT-Related Genes
that Are Elevated by SKM
To further determine the roles of OCT4 and GATA3 in inducing
pluripotency, we performed RNA-sequencing (RNA-seq) assays
at 7 dpi based on our kinetics test (Figures 1C and 1D). The
shared targets of OCT4 and GATA3 were involved in several
important processes, such as cell adhesion and the regulation
of transcription, based on gene ontology (GO) function enrich-
ment analysis (Figures 2C and 2D). Interestingly, we observed
that, compared with MEFs, the upregulated genes that were
most significantly enriched were related to ectoderm and
epidermis development following the introduction of SKM.
When OCT4 and GATA3 were introduced along with SKM, the
most significantly enriched downregulated genes were also
related to ectoderm and epidermis development (Figures 2E
and 2F). These results suggest that SKM may have the potential
to direct cells toward an ECT state and that the inhibition of ECT-
related genes byOCT4 andGATA3may facilitate the induction of
pluripotency.
Screening of Other Lineage Specifiers as Substitutes
for OCT4
Thecurrentmodel proposes that ESCsaremaintainedbya shield
of pluripotency factors that collaboratively prohibit differentiation
into any lineage to preserve an undifferentiated state (Boyer et al.,
2005; Silva et al., 2009). Amore recent and provocative perspec-
tive is that pluripotency factors function as classical lineage-
specifying factors to direct the differentiation of ESCs into a
specific lineage while inhibiting their commitment to mutually
exclusive lineages (Loh and Lim, 2011). In ESCs, Oct4 promotes
ME and primitive endoderm differentiation and suppresses ECT
differentiation (Niwa et al., 2000; Thomson et al., 2011; Wang
et al., 2012). Interestingly, the overexpression of Gata3 in ESCs
directs primitive endodermal differentiation, and similar to Oct4,
Gata3 also functions in some ME lineages (Nishiyama et al.,
2009). The similarity ofOCT4 andGATA3 in lineage specification
suggests that other lineage specifiersmay also replaceOCT4. To
test this possibility, we screened several additional lineage spec-
ifiers using viral overexpression (Table S3). The results indicated
that the lineage specifiersGATA6, SOX7, PAX1,GATA4,CEBPa,
HNF4a, and GRB2 were able to substitute for OCT4 to induce
pluripotency (Figures 3A, 3B, and S1E). These lineage specifiers
have been shown to functionmainly duringmultiple stages of ME
differentiation and in early embryonic patterning (Table S4). Most
of these substitutes for OCT4 are not enriched in ESCs (Fig-
ure S1D). However, the lineage specifiers that are primarily
involved in ectodermal lineage specification (e.g., SOX1 and
ASCL1) were unable to replace OCT4 (Table S3).
OtherOCT4 Substitutes Also Inhibit ECT-Related Genes
Elevated by SKM
Because both OCT4 and GATA3 attenuated the elevated
expression of the group of ECT genes that was collectively trig-
gered by SKM, we asked whether the other substitutes forOCT4
could also attenuate their expression. We performed microarray
assays to analyze the roles of other OCT4 substitutes. In addi-
tion, we analyzed another lineage specifier,MIXL1, as a negative
control, which could not replaceOCT4 despite its involvement inME lineage specification. Consistent with our expectations, the
otherOCT4 substitutes, but notMIXL1, attenuated the upregula-
tion of ECT genes by SKM (Figure 3C). GO analysis also showed
that the most significantly enriched downregulated genes after
the introduction of OCT4 substitutes other than MIXL1 were
associated with ectoderm and epidermis development and other
terms related to ECT specification (Figure S3).
Next, to validate the tendency apparent from the RNA-seq and
microarray analyses (Figures 2F and 3C), we performed real-time
quantitative PCR (RT-qPCR) assays. We observed that typical
ECT marker genes, such as Dlx3 and Lhx5, were upregulated
by SKM and significantly downregulated after the introduction
ofOCT4 and its substitutes (Figures 3D). To further validate these
findings, we performed single-colony assays. We acquired AP-
positive, Oct4-GFP-negative colonies in different conditions,
including controlled SKM conditions. Then, we mechanically
split each colony into two subcolonies. We analyzed one subcol-
ony for gene expression while tracing the other half subcolony in
culture to monitor whether it becameOct4-GFP positive and dox
independent (Figure S4). In this case, we could analyze those
reprogramming-competent colonies that were headed toward
pluripotency. AP-positive colonies grown in SKM conditions
failed to become Oct4-GFP positive, suggesting that they are
reprogramming refractory. We found a concomitant downregu-
lation ofDlx3 and Lhx5 after the introduction ofOCT4 and its sub-
stitutes (Figure 3E). This finding is consistent with the results
frommixed cell populations, supporting the lineage specification
tendency observed in the bulk population. These results suggest
that OCT4 and its substitutes can repress the upregulation of
ECT-related genes that are triggered by SKM.
Suppression of Dlx3, a Master ECT-Related Gene,
Facilitates Reprogramming in the Presence of SKM
To test whether the inhibition of ECT-related genes byOCT4 and
its substitutes correlated with the promotion of reprogramming,
we further evaluated whether the knockdown of the master ECT
lineage-related genes that are upregulated by SKM could also
promote reprogramming in the absence of OCT4. We found
that the knockdown of the key ECT marker Dlx3, which subse-
quently resulted in the downregulation of several other ECT
genes, promoted reprogramming in the absence ofOCT4, rather
than in the absence of SOX2 (Figures 4 and S5), functionally sup-
porting the data observed by gene profiling (Figures 2E, 2F, and
3C–3E). Furthermore, iPSCs generated with Dlx3 shRNAs were
proven to be pluripotent by stringent characterization assays
(Figures 4E, 4F, and Table S2). We found no significant binding
of Oct4 and Gata3 to the Dlx3 promoter region in published
ChIP data from ‘‘hmChIP,’’ which suggests that Oct4 and
Gata3 may indirectly regulate Dlx3 (Figure S5D). Together, our
data indicate thatOCT4 and its substitutes attenuate the upregu-
lation of ECT-related genes that is triggered by the SKM combi-
nation; this inhibition correlates with facilitating the induction of
pluripotency.
SOX2 and Its Substitutes Attenuate the Expression
of ME-Related Genes Elevated by OKM
Similar to Oct4, Sox2 also regulates lineage specification
in ESCs. Sox2 inhibits mesendodermal differentiation andCell 153, 963–975, May 23, 2013 ª2013 Elsevier Inc. 967
Figure 3. Identification of Other Substitutes
for OCT4 that also Inhibit ECT-Related
Genes Elevated by SKM during Repro-
gramming
(A) Identification of additional lineage specifiers
that are related to the ME lineage that can replace
OCT4 during reprogramming. The Oct4-GFP-
positive colonies were counted at 9 dpi. SKM plus
EV was used as a control. Error bars indicate the
SD (n = 3).
(B) GFP images of iPS colonies generated with
SKM+GATA6 (G6SKM), SKM+GATA3 (G3SKM),
SKM+SOX7 (S7SKM), SKM+PAX1 (P1SKM),
SKM+GATA4 (G4SKM), SKM+CEBPa (CaSKM),
SKM+HNF4a (H4SKM), and SKM+GRB2 (GrSKM).
Scale bars, 100 mm.
(C) Heatmaps depicting the relative fold change
of gene expression at 7 dpi based on the ECT-
related genes by microarray. Red and green
indicate increased and decreased expression,
respectively.
(D) RT-qPCR analysis of the expression of
endogenous Dlx3 (top) and Lhx5 (bottom) relative
to the expression in SKM. The samples were
tested at 7 dpi after removal of Oct4-GFP-posi-
tive cells. Significance was assessed compared
with the controls using a one-tailed Student’s
t test. ***p < 0.001. Error bars indicate the SD
(n = 3).
(E) RT-qPCR analysis of the expression of
endogenous Dlx3 (top) and Lhx5 (bottom)
relative to the expression in SKM from a
single colony; three colonies from each condi-
tion were tested. Significance was assessed
compared with the controls using a one-tailed
Student’s t test. *p < 0.05. Error bars indicate
the SD (n = 3).
See also Figures S3 and S4 and Tables S2,
S3, S4.promotes neural ectodermal differentiation (Thomson et al.,
2011; Wang et al., 2012). Intuitively, we asked whether the line-
age specifiers involved in ECT lineage specification could
substitute for SOX2 during reprogramming. Indeed, the previ-
ously identified SOX2 substitutes, Sox1, Sox3, and RCOR2,
are regulators of ECT development or are particularly exp-
ressed in neural tissues (Nakagawa et al., 2008; Tontsch
et al., 2001; Yang et al., 2011; Zeng et al., 2010). In addition,
we demonstrated that GMNN, which is involved in ECT968 Cell 153, 963–975, May 23, 2013 ª2013 Elsevier Inc.lineage specification (Seo et al., 2005),
could substitute for SOX2 to promote
reprogramming (Figures 5A, 5B, S1E,
and Table S4).
To assess whether SOX2 and its
substitutes could attenuate the upregu-
lation of the ME-related genes that are
induced by OCT4, KLF4, and c-MYC
(OKM), we performed microarray and
RT-qPCR analyses. The expression of a
group of classical ME markers was
elevated after the induction of OKM;these elevated expression levels were attenuated by SOX2
and its substitutes (Figures 5C and 5D). Furthermore, we per-
formed similar single-colony assays as previously mentioned
to test this tendency in reprogramming-competent cells. We
observed that SOX2 and its substitutes inhibited the expression
of T and Eomes in these colonies (Figure 5E). These data
indicate that SOX2 and its substitutes attenuate the upregula-
tion of ME-related genes that is induced by OKM during the
reprogramming process.
Figure 4. Inhibition of the Master ECT Gene
Dlx3 Facilitates Reprogramming in the
Presence of SKM
(A) shRNAs targeting Dlx3 were introduced into
MEFs with SKM or OKM. Scrambled shRNA
(control RNAi) was used as a control. The Oct4-
GFP-positive colonies were counted at 9 dpi. Error
bars indicate the SD (n = 3).
(B) RT-qPCR analysis of the expression of
endogenous Dlx3 relative to the expression in
control. SKM plus scramble shRNA (control RNAi)
was used as a control. The samples were tested at
7 dpi. Error bars indicate the SD (n = 3).
(C) Western blot analysis of DLX3 in control and
knockdown cells in the presence of a SKM virus
cocktail. GAPDH was used as a loading control.
(D) Phase and GFP images of iPS colonies
generated with Dlx3 RNAi 1 and Dlx3 RNAi 2 in the
presence of SKM. Scale bars, 100 mm.
(E) Adult chimeric mice generated from Dlx3 RNAi
2-induced iPSCs (#1).
(F) A germline transmission mouse (agouti) from
#1 is depicted.
See also Figure S5.A ‘‘Seesaw Model’’ Suggests that the Balancing
of Counteracting Forces Facilitates the Induction
of Pluripotency
A two-node model of cell fate determination has been studied in
various instances of pluripotent stem or progenitor cells that
undergo a binary cell fate decision (e.g., GATA1 and PU.1,
RUNX2, and PPARg) (Huang, 2009). This circuit has already
hinted at the concept of a ‘‘balanced pluripotent state’’ (Figures
S6A and S6B). To better understand the induction of pluripo-
tency by lineage specifiers, we propose a ‘‘seesaw model’’ (Fig-
ures 6A and 7) based on previous studies (Hanna et al., 2009; Loh
and Lim, 2011; Niakan et al., 2010; Niwa et al., 2000; Polo et al.,
2012; Rosa and Brivanlou, 2011; Teo et al., 2011; Thomson et al.,
2011; Wang et al., 2012) and our current data (Figures 2, 3, 4, 5,
S3, S4, and S5). This model consists of two coupled modules:
the pluripotency module and the differentiation module. The
pluripotency module is represented by the mutual activation of
Oct4 and Sox2, whereas the differentiation module is modeled
by mutually inhibiting the ME and ECT genes (Figure 6A).
Simulations of the model produced three cell states: the plu-
ripotency state, the ME state, and the ECT state (Figures 6B
and S6C). In somatic states, the pluripotency state is unreach-
able (Figure 6C, box i). However, overexpression of KLF4 andCell 153, 963–c-MYC (KM) may act as a driving force
that reduces reprogramming barriers
(Polo et al., 2012), so the pluripotency
state becomes a local attractor that is
reachable from a somatic state if properly
perturbed (Figure 6C, box ii). Note that the
pluripotent state is most easily reached
(high pluripotency potential) if the expres-
sion strengths of the ME and ECT genes
are forced to be in the blue region, i.e., if
they are balanced.A key result of this model is that pluripotency and reprogram-
ming can be achieved by a variety of perturbations to the
system, as illustrated in Figure 6D. For example, the overex-
pression of SOX2 alone will switch on the ECT genes that
inhibit the pluripotency module, in turn bestowing the ECT state
onto the cell, regardless of the initial cell state (Figures 6D, box
i, S6I, and S6N). The overexpression of OCT4 (or the ME gene
GATA3) in combination with SOX2 counteracts the inhibition of
the ECT genes to the pluripotency module, which permits the
cell to move into the pluripotency attractor region (Figures
6D, boxes ii and iii, S6D, and S6E). More strategies for restoring
pluripotency as suggested by the model are shown in Figures
6D and S6 and Tables S5 and S6.
Some of the results from our model are consistent with
previous studies (Table S6). Deviation from the balanced equi-
librium for pluripotency directs cells to flow into divergent
differentiated states. For example, the enforced expression of
OCT4 results in cellular transdifferentiation into mesodermal
hematopoietic cells (Szabo et al., 2010). SOX2, SKM with
neural lineage specifiers, and reduced Oct4 expression in the
OSKM cocktail can result in neuroectodermal lineage trans-
differentiation from fibroblasts (Han et al., 2012; Ring et al.,
2012; Thier et al., 2012). Other strategies identified by our975, May 23, 2013 ª2013 Elsevier Inc. 969
Figure 5. SOX2 and Its Substitutes Attenuate the Expression of ME Genes that Are Elevated by OKM during Reprogramming
(A) Identification of lineage specifiers related to the ECT lineage that can facilitate reprogramming in the presence of OKM. TheOct4-GFP-positive colonies were
counted at 9 dpi. OKM plus EV was used as a control. Error bars indicate the SD (n = 3).
(B) GFP images of iPS colonies generated with OKM+SOX1 (OS1KM), OKM+SOX3 (OS3KM), and OKM+GMNN (OGmKM). Scale bars, 100 mm.
(legend continued on next page)
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model call for further investigation to validate or falsify the
model.
One of the striking predictions of the model is that, when
expressed together, an ME specifier and an ECT specifier
can synergistically enhance reprogramming in the absence of
both OCT4 and SOX2. The mutually antagonistic nature of the
differentiation module makes the system behave like an easily
tilted ‘‘seesaw’’; when the system tends to fall into either the
ME or ECT state, in turn suppressing the pluripotency module,
the cell is left with no chance to enter the pluripotency state.
However, when both ME and ECT specifiers are exogenously
expressed at appropriate levels, their external expression may
be unable to compensate for the decrease in their endogenous
expression due to the mutual inhibition. The differentiation
module may end up in the balanced region, wherein neither
ME specifiers nor ECT specifiers are present at levels that are
sufficiently high to suppress the pluripotency module. Then, a
self-activating pluripotency module may switch on by itself,
eliciting the serial activation of a pluripotency network to
realize successful reprogramming (Figures 6D, box v, S6G,
and S6R–S6T).
To test the feasibility of this idea, we screened different com-
binations of lineage specifiers. We found that either (1) GATA3,
GATA6, PAX1, and SOX1 or SOX3 or (2) GATA6 plus GMNN
can promote successful reprogramming without the two most
critical pluripotency factors, OCT4 and SOX2 (Figures 6E, 6F,
and S1E). Furthermore, these iPSCs were proven to be
pluripotent (Figure S7). These lineage specifiers are not
enriched in ESCs (Figure S1D), which indicates that the induc-
tion and maintenance of pluripotency may be two different
scenarios.
DISCUSSION
Our data present the first evidence that the lineage specifiers
GATA3, GATA6, SOX7, PAX1, GATA4, CEBPa, HNF4a,
GRB2, and GMNN, which are generally considered as pluripo-
tency rivals, can unexpectedly facilitate reprogramming and
replace reprogramming factors of a corresponding lineage-
specifying potential. We suggest a ‘‘seesaw model’’ in which
lineage specifiers facilitate reprogramming when they are
balanced with other mutually exclusive lineage specifiers. There
are multiple ways to reach the pluripotency state, all involving
balancing the forces that would otherwise drive the cell to a
differentiated fate. Deviation from the balance directs cells to
divergent differentiated states, reducing the possibility of
restoring pluripotency. This hypothesis is complementary to
previous studies demonstrating that lineage specifiers such
as Gata6, a reported repressor of Nanog, hinder the reprogram-
ming process (Chazaud et al., 2006; Mikkelsen et al., 2008).(C) Heatmaps depicting the relative fold change of gene expression at 7 dpi based
decreased expression, respectively.
(D) RT-qPCR analysis of the expression of endogenous T (left) and Eomes (right) re
controls using a one-tailed Student’s t test. ***p < 0.001. The samples were test
(E) The expression of endogenous T (top) and Eomes (bottom) relative to the exp
tested. Significance was assessed compared with the controls using a one-taile
See also Figure S4 and Tables S2 and S4.We suggest that pluripotency factors may direct lineage spec-
ification and that lineage specifiers may in turn influence the
induction of pluripotency; this model provides the conceptually
new perspective that one can reach the pluripotency ‘‘destina-
tion’’ by getting on cars that do not normally run at the
destination.
Our ‘‘seesaw model’’ is in agreement with the recent perspec-
tive that pluripotency factors act as classical lineage-specifying
factors to direct the differentiation of ESCs into a specific lineage
while cross-inhibiting commitment to mutually exclusive line-
ages (Loh and Lim, 2011). The collaborative result is the tempo-
rary inhibition of all lineages to preserve an undifferentiated
state. The self-activating pluripotency module could be acti-
vated when all of the lineage-specifying forces are counter-
acted, i.e., at the dynamic balanced point of the ‘‘seesaw,’’
wherein no particular lineage-specifying activity is dominant to
inhibit the pluripotency module. Once the pluripotency module
is activated, the ME and ECT lineage fates are blocked by
SOX2 and OCT4, respectively, and the pluripotency state is
maintained.
Most of these substitutes are usually depicted as typical ME
markers (GATA6, GATA4, etc.) or ECT markers (SOX1, SOX3,
etc.). To make our model succinct, these lineage specifiers are
classified as either ME or ECT. However, this classification is
not absolute, as indicated by our ‘‘seesaw model.’’ The ME
and ECT lineages are the two major counteracting lineages,
but in the reprogramming symphony, an enormously intricate
self-conflicted coalition of different lineage specifiers that are
not limited to the ME and ECT lineages orchestrates the
concerted induction of pluripotency.
The ‘‘seesaw model’’ focuses on one major aspect in reprog-
ramming: understanding the implications of the reprogramming
landscape that is shaped by the interactions among the different
cell states. Needless to say, reprogramming is not merely a
‘‘seesaw.’’ Several other important events, such as epigenetic
changes, are also involved in this process. Furthermore, there
are several important barriers to overcome for successful
reprogramming. The various reprogramming factors execute
their corresponding functions to facilitate the induction of plurip-
otency. Concomitantly, these factors may induce side effects,
such as the stimulation of lineage specification. In addition to
their reported functions in the activation of the pluripotency
circuitry and in epigenetic and cell-cycle regulation, KLF4 and
c-MYC may also promote stimuli for particular lineages (Cao
et al., 2012; Smith et al., 2010; Sridharan et al., 2009) to concert
an equilibrium symphony. The function of these lineage speci-
fiers may be involved in other processes and warrants further
in-depth study.
We hope that our model can serve as a starting point to
decipher the mysterious reprogramming code in a novelon theME-related genes by microarray. Red and green indicate increased and
lative to the expression in OKM. Significance was assessed compared with the
ed at 7 dpi. Error bars indicate the SD (n = 3).
ression in OKM from a single colony; three colonies from each condition were
d Student’s t test. *p < 0.05, ***p < 0.001. Error bars indicate the SD (n = 3).
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Figure 6. Balanced Equilibrium Facilitates the Induction of Pluripotency
(A) A model for the coupled pluripotency module (self-activation of Oct4 and Sox2) and for the differentiation module (mutual antagonism between the ME and
ECT lineages).
(B) The cell-state landscape obtained from the density of the trajectories. The blue color indicates deep ‘‘attractors’’ near which the cell states tend to stay. The
x axis represents the difference between the two groups of lineage inducers, and the y axis indicates the ‘‘pluripotency’’ of the cell.
(legend continued on next page)
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Figure 7. The ‘‘Seesaw Model’’
A diagram of the ‘‘seesaw model.’’ Blue clouds
indicate the regions that the cell states are likely to
sample with noise. The pluripotency state (red ball)
is located near the balanced region. When the
seesaw is balanced between the two differentia-
tion potentials, the cell has a higher probability of
entering the pluripotent state.scenario. Our results suggest that a chemical screen for small
molecules that can substitute for OCT4 and SOX2 in directing
the corresponding lineage specification would be a novel
and feasible strategy to generate iPSCs. Our findings also
demonstrate the need for further investigation of the conven-
tional perspectives regarding the functions of pluripotency
factors and lineage specifiers and on the manner in which
the pluripotency regulatory circuitry is established during
reprogramming.
EXPERIMENTAL PROCEDURES
Screen
The 10,080 cDNAs that were screened for their ability to replace OCT4 were
obtained from Origene Co., Ltd. Oct4-GFP MEFs were infected with SKM
(SOX2, KLF4, and c-MYC) lentiviral supernatant (MOI: 4) supplemented with
10 ng/ml polybrene (Sigma) for 12 hr. Details are provided in the Extended
Experimental Procedures.
Cell Culture
PrimaryMEFs,mouseGECs, keratinocytes, andMDFswere derived from ICR3
Oct4-GFP transgenic mice. Mouse GECs were isolated and cultured as previ-
ously described (Aoi et al., 2008). Details are provided in the Extended Exper-
imental Procedures.
iPSCs Generation
The dox-inducible lentiviral system used has been previously described
(Maherali et al., 2008). Further details are provided in the Extended Experi-
mental Procedures.
Time Course of GATA3 Induction
A dox-inducible lentiviral system was used, so the expression of tet-GATA3,
but not pll3.7-DU6DGFP-SOX2, pll3.7-DU6DGFP-KLF4, or pll3.7-DU6DGFP-
c-MYC (Zhao et al., 2008), could be induced by dox. Dox was added to the(C and D) The phase space without (box i)/with KM (box ii) under no input, respectively (C). Different reprogram
from the ME state are shown (D). The blue circuit indicates the ME state where the trajectories start. Yell
directions of cell states are marked by arrows. The trajectories that end up in theME state, the ECT state, and t
red, respectively. Cyan indicates the region where the reprogramming is possible. Dark lines are the nullclines
module is OFF. When the stable crossing point falls into the cyan reprogramming region, pluripotency can b
(E) The generation of mouse iPSCs in the absence of bothOCT4 andSOX2. KM plus EVwas used as a control.
dpi. Error bars indicate the SD (n = 3).
(F) GFP images of iPS colonies generatedwith KM+GATA3+SOX1 (G3S1KM), KM+GATA3+SOX3 (G3S3KM),
(G6S3KM), KM+GATA6+GMNN (G6GmKM), KM+PAX1+SOX1 (P1S1KM), KM+PAX1+SOX3 (P1S3KM), and
See also Figures S6 and S7 and Tables S5 and S6.
Cell 153, 963–culture medium for different periods of time, and
the number of Oct4-GFP-positive colonies was
counted at 10 dpi.
Characterization of iPSCs
The teratoma formation and chimera experiments
were performed as previously described (Li et al.,
2011). The primers used for RT-PCR, genomicPCR, and RT-qPCR are listed in Table S7. Bisulfite treatment of DNA was per-
formed using the CpGenome Fast DNA Modification Kit (Millipore). The
primers used for promoter fragment amplification have been previously
described (Takahashi and Yamanaka, 2006). The details for immunofluores-
cence and the detection of AP activity are provided in the Extended Experi-
mental Procedures.
Single-Colony Analysis
Five days after infection with different reprogramming cocktails, Alkaline Phos-
phatase Live Stain (Invitrogen) was used for the detection of AP activity. AP-
positive colonies were then picked, and each colony was divided into two
parts. One part was kept culturing in induction medium for 2–4 days. The other
part was frozen at 80C. If Oct4-GFP turned on after an additional 2–4 days
induction and became dox independent in 4 days without dox, total RNA was
isolated from the frozen part using the RNeasy micro kit (QIAGEN) and then
used for RT-qPCR analysis.
Knockdowns
Dlx3 knockdown was achieved using shRNA lentiviral vectors (Sigma) contain-
ing a puromycin resistance gene. Further details are provided in the Extended
Experimental Procedures.
Western Blotting
Cells were washed with PBS, treated with 1 3 SDS sample buffer, and then
boiled. Additional details are provided in the Extended Experimental
Procedures.
DNA Microarray
Total mRNA from iPSCs, MEFs, MEFs at 7 dpi, and R1 were labeled with Cy5
hybridized to a mouse oligo microarray (Phalanx Mouse Whole Genome
OneArray; Phalanx Biotech). The data were analyzed according to the manu-
facturer’s protocol.
RNA-Seq
RNA-sequencing libraries were constructed using the Illumina mRNA-seq
Prep Kit. The fragmented and randomly primed 200 bp paired-end librariesming strategies with KM and the trajectory starting
ow dots indicate stable cell states. The changing
he pluripotent state are colored by blue, green, and
of the differentiation module when the pluripotency
e restored.
TheOct4-GFP-positive colonies were counted at 9
KM+GATA6+SOX1 (G6S1KM), KM+GATA6+SOX3
OSKM. Scale bars, 100 mm.
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were sequenced using Illumina HiSeq 2000. Details are included in the
Extended Experimental Procedures.
Statistical Analysis
Cell proliferation curves were analyzed using a paired two-tailed Student’s
t test. The unpaired one-tailed t test was used for statistical analysis of other
experiments. The standard deviation (SD) was used to quantify variability.
Model Construction
A coarse-grained model was built based on our results and the results of
previous studies. The interactions involved in this model are illustrated in
Figure 6A. Additional details are provided in the Extended Experimental
Procedures.
ACCESSION NUMBERS
Microarray and RNA-seq data are available in the Gene Expression Omnibus
(GEO) database (http://www.ncbi.nlm.nih.gov/geo/) under the accession
number GSE43995.
SUPPLEMENTAL INFORMATION
Supplemental Information includes the Extended Experimental Procedures,
seven figures, and seven tables and can be found with this article online at
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